RNA FY 2023 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RNAAvidity Biosciences, Inc.

$2B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M+3.6% YoY

Gross Profit

$7M78.0% margin

Operating Income

-$236M-2464.4% margin

Net Income

-$212M-2219.9% margin

EPS (Diluted)

$-2.91

Cash Flow

Operating Cash Flow

-$119M

Free Cash Flow

-$123M

Stock-Based Comp.

$38M

Balance Sheet

Total Assets

$629M

Total Liabilities

$128M

Stockholders' Equity

$501M

Cash & Equivalents

$185M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$9M	+3.6%
Gross Profit	$7M	$8M	-4.8%
Operating Income	-$236M	-$179M	-31.7%
Net Income	-$212M	-$174M	-22.0%